These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Galvan B; Christopoulos TK; Diamandis EP Clin Chem; 1995 Dec; 41(12 Pt 1):1705-9. PubMed ID: 7497609 [TBL] [Abstract][Full Text] [Related]
3. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format. Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064 [TBL] [Abstract][Full Text] [Related]
4. Quantification of prostate-specific antigen mRNA by coamplification with a recombinant RNA internal standard and microtiter well-based hybridization. Verhaegen M; Ioannou PC; Christopoulos TK Clin Chem; 1998 Jun; 44(6 Pt 1):1170-6. PubMed ID: 9625039 [TBL] [Abstract][Full Text] [Related]
5. Quantitative RT-PCR combined with time-resolved fluorometry for determination of BCR-ABL mRNA. Bortolin S; Christopoulos TK Clin Chem; 1996 Dec; 42(12):1924-9. PubMed ID: 8969627 [TBL] [Abstract][Full Text] [Related]
6. Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes. Ylikoski A; Karp M; Lilja H; Lövgren T Biotechniques; 2001 Apr; 30(4):832-6, 838, 840 passim. PubMed ID: 11314266 [TBL] [Abstract][Full Text] [Related]
7. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538 [TBL] [Abstract][Full Text] [Related]
8. Quantitative reverse transcription-PCR assay with an internal standard for the detection of prostate-specific antigen mRNA. Ylikoski A; Sjöroos M; Lundwall A; Karp M; Lövgren T; Lilja H; Iitiä A Clin Chem; 1999 Sep; 45(9):1397-407. PubMed ID: 10471641 [TBL] [Abstract][Full Text] [Related]
9. Bioluminescence hybridization assays using recombinant aequorin. Application to the detection of prostate-specific antigen mRNA. Galvan B; Christopoulos TK Anal Chem; 1996 Oct; 68(20):3545-50. PubMed ID: 8865762 [TBL] [Abstract][Full Text] [Related]
10. Time-resolved immunofluorometric determination of specific mRNA sequences amplified by the polymerase chain reaction. Bortolin S; Christopoulos TK Anal Chem; 1994 Dec; 66(23):4302-7. PubMed ID: 7847630 [TBL] [Abstract][Full Text] [Related]
11. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386 [TBL] [Abstract][Full Text] [Related]
12. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285 [TBL] [Abstract][Full Text] [Related]
13. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. Gomella LG; Raj GV; Moreno JG J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297 [TBL] [Abstract][Full Text] [Related]
14. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application]. Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839 [TBL] [Abstract][Full Text] [Related]
15. Detection of BCR-ABL transcripts from the Philadelphia translocation by hybridization in microtiter wells and time-resolved immunofluorometry. Bortolin S; Christopoulos TK Clin Chem; 1995 May; 41(5):693-9. PubMed ID: 7729047 [TBL] [Abstract][Full Text] [Related]
16. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296 [TBL] [Abstract][Full Text] [Related]
17. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients. Straub B; Müller M; Krause H; Schrader M; Miller K Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428 [TBL] [Abstract][Full Text] [Related]
18. Quantitative PSA RT-PCR for preoperative staging of prostate cancer. Kurek R; Ylikoski A; Renneberg H; Konrad L; Aumüller G; Roddiger SJ; Zamboglou N; Tunn UW; Lilja H Prostate; 2003 Sep; 56(4):263-9. PubMed ID: 12858354 [TBL] [Abstract][Full Text] [Related]
19. Quantitative polymerase chain reaction using a recombinant DNA internal standard and time-resolved fluorometry. Bortolin S; Christopoulos TK; Verhaegen M Anal Chem; 1996 Mar; 68(5):834-40. PubMed ID: 8779442 [TBL] [Abstract][Full Text] [Related]
20. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. Gala JL; Heusterspreute M; Loric S; Hanon F; Tombal B; Van Cangh P; De Nayer P; Philippe M Clin Chem; 1998 Mar; 44(3):472-81. PubMed ID: 9510850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]